The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles
Open accessAbstract
This paper reviews the major factors that are closely involved in peptide and protein degradation during the preparation of biodegradable nano- and microparticles. The various means usually employed for overcoming these obstacles are described, in order to bring to the fore the strategies for protein stabilization. Both processing and formulation parameters can be modified and are distinctly considered from a strategic point of view. We describe how partial or full protein stability retention within the carriers and during drug release might be achieved by individual or combined optimized strategies. Additionally, problems commonly encountered during protein quantification, stability determination and release are briefly reviewed. Artefacts that might occur during sampling and analytical procedures and which might hinder critical interpretation of results are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Suslick, K. S., Hammerton, D. A., & Cline, R. E. (1986) · Journal of the American Chemical Society · doi:10.1021/ja00278a055 · Cited by 1,243
Stability of Protein Pharmaceuticals
Manning, M. C., Patel, K., & Borchardt, R. T. (1989) · Pharmaceutical Research · doi:10.1023/a:1015929109894 · Cited by 1,078
Instability, stabilization, and formulation of liquid protein pharmaceuticals
Wang, W. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00152-0 · Cited by 1,064
Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres
Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L. H., & Langer, R. (1991) · Pharmaceutical Research · doi:10.1023/a:1015841715384 · Cited by 843
Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles
van de Weert, M., Hennink, W. E., & Jiskoot, W. (2000) · Pharmaceutical Research · doi:10.1023/a:1026498209874 · Cited by 708
On Protein Denaturation in Aqueous−Organic Mixtures but Not in Pure Organic Solvents
Griebenow, K., & Klibanov, A. M. (1996) · Journal of the American Chemical Society · doi:10.1021/ja961869d · Cited by 400
Biodegradable microspheres as controlled-release tetanus toxoid delivery systems
Alonso, M. J., Gupta, R. K., Min, C., Siber, G. R., & Langer, R. (1994) · Vaccine · doi:10.1016/0264-410x(94)90092-2 · Cited by 313
Glomme, A., März, J., & Dressman, J. B. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20212 · Cited by 295
Solid‐state chemical stability of proteins and peptides
Lai, M. C., & Topp, E. M. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980374e · Cited by 285
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
Blanco, M. D., & Alonso, M. J. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00056-8 · Cited by 269
Cleland, J. L., & Jones, A. J. S. (1996) · Pharmaceutical Research · doi:10.1023/a:1016063109373 · Cited by 266
Crotts, G., & Park, T. G. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809008253 · Cited by 263
Park, T. G., Lu, W., & Crotts, G. (1995) · Journal of Controlled Release · doi:10.1016/0168-3659(94)00084-8 · Cited by 255
Blanco, D., & Alonso, M. J. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00011-3 · Cited by 251
Recent Advances in the Stabilization of Proteins Encapsulated in Injectable PLGA Delivery Systems
Schwendeman, S. P. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i1.20 · Cited by 235
The effect of a water/organic solvent interface on the structural stability of lysozyme
van de Weert, M., Hoechstetter, J., Hennink, W. E., & Crommelin, D. J. A. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00277-7 · Cited by 228
Cleland, J. L., Duenas, E. T., Park, A., Daugherty, A., Kahn, J., Kowalski, J., & Cuthbertson, A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00258-9 · Cited by 222
The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres
Johnson, O. L., Jaworowicz, W., Cleland, J. L., Bailey, L., Charnis, M., Duenas, E., Wu, C., Shepard, D., Magil, S., Last, T., et al. (1997) · Pharmaceutical Research · doi:10.1023/a:1012142204132 · Cited by 217
Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination
Johansen, P. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00079-5 · Cited by 210
Fu, K., Griebenow, K., Hsieh, L., Klibanov, A. M., & Langer, R. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00192-8 · Cited by 201
Precipitation of Proteins in Supercritical Carbon Dioxide
Winters, M. A., Knutson, B. L., Debenedetti, P. G., Sparks, H. G., Przybycien, T. M., Stevenson, C. L., & Prestrelski, S. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950482q · Cited by 200
Preparation and characterization of protein C-loaded PLA nanoparticles
Zambaux, M. F., Bonneaux, F., Gref, R., Dellacherie, E., & Vigneron, C. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00073-5 · Cited by 200
Park, T. G., Yong Lee, H., & Sung Nam, Y. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00050-9 · Cited by 198
Jiang, W., & Schwendeman, S. P. (2001) · Pharmaceutical Research · doi:10.1023/a:1011009117586 · Cited by 192
Morlock, M., Koll, H., Winter, G., & Kissel, T. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(96)00017-3 · Cited by 188
Protein Spray-Freeze Drying. Effect of Atomization Conditions on Particle Size and Stability
Costantino, H. R., Firouzabadian, L., Hogeland, K., Wu, C., Beganski, C., Carrasquillo, K. G., Córdova, M., Griebenow, K., Zale, S. E., & Tracy, M. A. (2000) · Pharmaceutical Research · doi:10.1023/a:1007570030368 · Cited by 186
Carrasquillo, K. G., Stanley, A. M., Aponte-Carro, J. C., De Jésus, P., Costantino, H. R., Bosques, C. J., & Griebenow, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00430-8 · Cited by 181
Jung, T., Kamm, W., Breitenbach, A., Hungerer, K.-D., Hundt, E., & Kissel, T. (2001) · Pharmaceutical Research · doi:10.1023/a:1011063232257 · Cited by 177
Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems.
Lu, W., & Park, T. G. (1995) · PubMed · Cited by 177
Manuela Gaspar, M., Blanco, D., Cruz, M. E. M., & José Alonso, M. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00196-x · Cited by 175
Controlled Delivery Systems for Proteins Using Polyanhydride Microspheres
Tabata, Y., Gutta, S., & Langer, R. (1993) · Pharmaceutical Research · doi:10.1023/a:1018929531410 · Cited by 167
Péan, J.-M., Venier-Julienne, M.-C., Boury, F., Menei, P., Denizot, B., & Benoit, J.-P. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00086-8 · Cited by 166
Preparation and characterization of alginate microspheres containing a model antigen
Lemoine, D., Wauters, F., Bouchend'homme, S., & Préat, V (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00303-2 · Cited by 165
Rosa, G. D., Iommelli, R., Rotonda, M. I. L., Miro, A., & Quaglia, F. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00315-1 · Cited by 164
Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha
Sánchez, A., Tobı́o, M., González, L., Fabra, A., & Alonso, M. J. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00019-8 · Cited by 162
Pegylation enhances protein stability during encapsulation in PLGA microspheres
Diwan, M., & Park, T. G. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00292-9 · Cited by 161
Crotts, G., & Park, T. G. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01511-8 · Cited by 160
Stabilizing insulin-like growth factor-I in poly(d,l-lactide-co-glycolide) microspheres
Meinel, L., Illi, O., Zapf, J., Malfanti, M., Merkle, H. P., & Gander, B. A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00352-7 · Cited by 160
Jiang, G. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00533-8 · Cited by 158
Elvassore, N., Bertucco, A., & Caliceti, P. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1113 · Cited by 155
Johansen, P., Men, Y., Audran, R., Corradin, G., Merkle, H. P., & Gander, B. A. (1998) · Pharmaceutical Research · doi:10.1023/a:1011998615267 · Cited by 153
Yamaguchi, Y., Takenaga, M., Kitagawa, A., Ogawa, Y., Mizushima, Y., & Igarashi, R. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00060-3 · Cited by 153
Péan, J., Boury, F., Venier‐Julienne, M., Meneï, P., Proust, J. E., & Benoît, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1014818118224 · Cited by 147
Protein behavior at the water/methylene chloride interface
Sah, H. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9900654 · Cited by 147
Castellanos, I. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00488-1 · Cited by 134
Insulin containing polyethylenimine–dextran sulfate nanoparticles
Tiyaboonchai, W., Woiszwillo, J., Sims, R. C., & Middaugh, C. R. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00055-3 · Cited by 123
Li, X., Zhang, Y., Yan, R., et al. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00235-2 · Cited by 122
Niwa, T., Takeuchi, H., Hino, T., Kunou, N., & Kawashimà, Y. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830527 · Cited by 122
Bilati, U., Allémann, É., & Doelker, É. (2003) · Pharmaceutical Development and Technology · doi:10.1081/pdt-120017517 · Cited by 118
Self-citationCharacterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy
Chen, L., Apte, R. N., & Cohen, S. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01496-4 · Cited by 115
Bittner, B., Morlock, M. M., Koll, H., Winter, G., & Kissel, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00012-5 · Cited by 113
van de Weert, M., Hof, R. V., van der Weerd, J., Heeren, R. M. A., Posthuma, G., Hennink, W. E., & Crommelin, D. J. A. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00227-3 · Cited by 112
Morlock, M. M., Kissel, T., Li, Y. X., Koll, H., & Winter, G. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00070-4 · Cited by 112
Woo, B. H., Jiang, G., Jo, Y. W., & DeLuca, P. P. (2001) · Pharmaceutical Research · doi:10.1023/a:1013090700443 · Cited by 106
Takada, S., Yamagata, Y., Misaki, M., Taira, K., & Kurokawa, T. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00494-7 · Cited by 103
Lam, X. M., Duenas, E. T., & Cleland, J. L. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1088 · Cited by 100
Kang, F., Jiang, G., Hinderliter, A. K., DeLuca, P. P., & Singh, J. (2002) · Pharmaceutical Research · doi:10.1023/a:1015354028908 · Cited by 96
Chang, A.-C., & Rk, G. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950365v · Cited by 96
A New Strategy To Determine the Actual Protein Content of Poly(lactide-co-glycolide) Microspheres
Sah, H. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960363q · Cited by 91
Castellanos, I. J., Carrasquillo, K. G., López, J. D. J., Alvarez, M., & Griebenow, K. H. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775361 · Cited by 90
Sánchez, A., Villamayor, B., Guo, Y.-Y., et al. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00178-7 · Cited by 88
Quaglia, F., Rosa, G. D., Granata, E., Ungaro, F., Fattal, E., & Rotonda, M. I. L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00414-5 · Cited by 86
Secondary Structure Characterization of Microparticulate Insulin Powders†
Yeo, S., Debenedetti, P. G., Patro, S. Y., & Przybycien, T. M. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600831203 · Cited by 85
Wolf, M., Wirth, M., Pittner, F., et al. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00071-1 · Cited by 83
Chemical stability of insulin. 3. Influence of excipients, formulation, and pH.
Brange, J., & Langkjær, L. (1992) · PubMed · Cited by 82
Protein–fatty acid complex for enhanced loading and stability within biodegradable nanoparticles
Yoo, H. S., Choi, H., & Park, T. G. (2001) · Journal of Pharmaceutical Sciences · Cited by 81
Na, D. H., Youn, Y. S., Lee, S. D., Son, M., Kim, W. B., DeLuca, P. P., & Lee, K. C. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00366-3 · Cited by 80
PEREZRODRIGUEZ, C., Montano, N., González, K., & Griebenow, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00074-9 · Cited by 78
PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers
Li, Y., Pei, Y., Zhou, Z.-H., Zhang, X., Gu, Z.-H., Ding, J., Zhou, J.-J., & Gao, X.-J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00235-8 · Cited by 76
Leobandung, W., Ichikawa, H., Fukumori, Y., & Peppas, N. A. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00028-7 · Cited by 73
Pérez, C., Jésus, P. D., & Griebenow, K. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00435-0 · Cited by 73
Stabilization of Dichloromethane-Induced Protein Denaturation During Microencapsulation
Raghuvanshi, R. S., Goyal, S., Singh, O., et al. (1998) · Pharmaceutical Development and Technology · doi:10.3109/10837459809028504 · Cited by 68
Adsorption of Salmon Calcitonin to PLGA Microspheres
Çalış, S., Jeyanthi, R., Tsai, T., et al. (1995) · Pharmaceutical Research · doi:10.1023/a:1016278902839 · Cited by 63
Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid
Rk, G., Chang, A.-C., Griffin, P., Rivera, R., Guo, Y.-Y., & Siber, G. R. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00233-2 · Cited by 61
Improved immunogenicity of a core-coated tetanus toxoid delivery system
Tobío, M. T. B., Schwendeman, S. P., Guo, Y., McIver, J., Langer, R., & Alonso, M. J. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00313-8 · Cited by 59
Enhanced Immunogenicity of Microencapsulated Tetanus Toxoid with Stabilizing Agents
Audran, R., Men, Y., Johansen, P., Gander, B. A., & Corradin, G. (1998) · Pharmaceutical Research · doi:10.1023/a:1011950732105 · Cited by 53
The effect of poly(ethylene glycol)–poly(d,l-lactic acid) diblock copolymers on peptide acylation
Lucke, A., Fustella, E., Teßmar, J., Gazzaniga, A., & Göpferich, A. M. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00020-2 · Cited by 53
Reduction of structural perturbations in bovine serum albumin by non-aqueous microencapsulation
Carrasquillo, K. G., Carro, J. C. A., Alejandro, A., Toro, D. D., & Griebenow, K. H. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775091 · Cited by 52
Kostanski, J. W., Thanoo, B. C., & DeLuca, P. P. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100102043 · Cited by 52
Immunogenicity of rDNA-derived pharmaceuticals
Ryff, J. ‐. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02024-2 · Cited by 51
Stabilization of pH-Induced Degradation of Porcine Insulin in Biodegradable Polyester Microspheres
Shao, P. G., & Bailey, L. C. (1999) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100101402 · Cited by 51
Takahata, H. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00145-4 · Cited by 51
Protein C-loaded monomethoxypoly (ethylene oxide)–poly(lactic acid) nanoparticles
Zambaux, M. F. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00548-2 · Cited by 51
Sharif, S., & O’Hagan, D. T. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00318-y · Cited by 49
Jiang, W., & Schwendeman, S. P. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1106 · Cited by 49
Yeh, M. (2000) · Journal of Microencapsulation · doi:10.1080/02652040050161738 · Cited by 47
Characterization of Protein and Peptide Stability and Solubility in Non-Aqueous Solvents
Stevenson, C. L. (2000) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201003378942 · Cited by 47
Secondary structure alterations in insulin and growth hormone water-in-oil emulsions
Jørgensen, L. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00668-3 · Cited by 44
Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs
Johansen, P., Tamber, H., Merkle, H. P., & Gander, B. A. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00095-2 · Cited by 41
Peptide and protein pegylation II – clinical evaluation
(2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00107-8 · Cited by 29
Desai, J. M. H. M. P. (2000) · Journal of Microencapsulation · doi:10.1080/026520400288454 · Cited by 25
Cited by
Polymer-based nanocapsules for drug delivery
Mora-Huertas, C. E., Fessi, H., & Elaissari, A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.018 · Cited by 1,742
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review
Fredenberg, S., Wahlgren, M., Reslow, M., & Axelsson, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.049 · Cited by 1,286
Hydrogels for Protein Delivery
Vermonden, T., Censi, R., & Hennink, W. E. (2012) · Chemical Reviews · doi:10.1021/cr200157d · Cited by 1,091
PLGA-Based Nanoparticles as Cancer Drug Delivery Systems
Tabatabaei Mirakabad, F. S., Nejati-Koshki, K., Akbarzadeh, A., Yamchi, M. R., Milani, M., Zarghami, N., Zeighamian, V., Rahimzadeh, A., Alimohammadi, S., Hanifehpour, Y., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.2.517 · Cited by 542
Silk fibroin nanoparticle as a novel drug delivery system
Mottaghitalab, F., Farokhi, M., Shokrgozar, M. A., Atyabi, F., & Hosseinkhani, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.020 · Cited by 444
Metadata
- Authors
- Bilati, U., Allémann, E., & Doelker, E.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 59
- Issue
- 3
- Pages
- 375-388
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2071521950
- Cited by
- 313
- References
- 91
- FWCI
- 7.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.